HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun Peng Selected Research

Ovarian Neoplasms (Ovarian Cancer)

11/2022Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets.
8/2021Multi-drug-resistance efflux in cisplatin-naive and cisplatin-exposed A2780 ovarian cancer cells responds differently to cell culture dimensionality.
4/2020Metabolic mapping with plasmonic nanoparticle assemblies.
12/2019Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
4/2019miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
1/2019Cytometry of Reaction Rate Constant: Measuring Reaction Rate Constant in Individual Cells To Facilitate Robust and Accurate Analysis of Cell-Population Heterogeneity.
1/2018miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
8/2016MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.
5/2011Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin.
2/2011MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun Peng Research Topics

Disease

13Neoplasms (Cancer)
02/2023 - 05/2011
11Ovarian Neoplasms (Ovarian Cancer)
11/2022 - 11/2008
10Pre-Eclampsia (Preeclampsia)
01/2022 - 03/2011
8Breast Neoplasms (Breast Cancer)
01/2019 - 02/2009
6Ovarian Epithelial Carcinoma
11/2022 - 11/2004
5Neoplasm Metastasis (Metastasis)
11/2022 - 03/2013
4Carcinogenesis
12/2019 - 11/2004
3Infections
01/2024 - 10/2006
2COVID-19
07/2022 - 11/2020
2Hepatocellular Carcinoma (Hepatoma)
03/2022 - 02/2022
2Pregnancy Complications
01/2022 - 03/2013
2Choriocarcinoma
09/2014 - 04/2002
1Inflammation (Inflammations)
01/2024
1Dysbiosis
11/2022
1Gram-Negative Bacterial Infections
04/2021
1Escherichia coli Infections
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Virus Diseases (Viral Diseases)
01/2019
1Alcoholic Fatty Liver
05/2017
1Glioma (Gliomas)
04/2017
1Spontaneous Abortion (Miscarriage)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Hypoxia (Hypoxemia)
01/2016
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2016
1Stroke (Strokes)
11/2015
1Fibroadenoma
12/2012
1Noninfiltrating Intraductal Carcinoma (DCIS)
12/2012
1Lymphatic Metastasis
12/2012
1Ductal Carcinoma
12/2012
1Carcinoma (Carcinomatosis)
02/2011

Drug/Important Bio-Agent (IBA)

11MicroRNAs (MicroRNA)IBA
01/2022 - 02/2011
10Activin Receptors (Activin Receptor)IBA
01/2016 - 11/2004
7Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2006
5Circular RNAIBA
11/2022 - 11/2018
4Biomarkers (Surrogate Marker)IBA
11/2022 - 08/2012
4Cisplatin (Platino)FDA LinkGeneric
08/2021 - 02/2011
4Transforming Growth Factor beta (TGF-beta)IBA
11/2008 - 11/2004
3Colistin (Coly-Mycin)FDA Link
09/2022 - 01/2021
3Cyclin G2IBA
04/2019 - 11/2008
3Phosphotransferases (Kinase)IBA
02/2009 - 04/2006
2Messenger RNA (mRNA)IBA
01/2018 - 01/2016
2Epidermal Growth Factor (EGF)IBA
01/2017 - 03/2013
2Activins (Activin)IBA
01/2016 - 01/2012
2LigandsIBA
12/2012 - 02/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2012 - 11/2004
1baicalinIBA
01/2024
1NucleosidesIBA
01/2024
1D-luciferinIBA
02/2023
1Anti-Bacterial Agents (Antibiotics)IBA
11/2022
15'-palmitoyl cytarabine (PLAC)IBA
07/2022
1terreinIBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Estrogens (Estrogen)FDA Link
11/2020
1Adenosine Triphosphate (ATP)IBA
04/2020
1CateninsIBA
12/2019
1XenobioticsIBA
01/2019
1CholesterolIBA
05/2017
1LipidsIBA
05/2017
1hexitolIBA
04/2017
1Antineoplastic Agents (Antineoplastics)IBA
04/2017
1Epoxy Compounds (Epoxides)IBA
04/2017
1DianhydrogalactitolIBA
04/2017
1CyclinsIBA
01/2017
1Heme Oxygenase-1IBA
01/2017
1AntigensIBA
01/2017
1CalpainIBA
01/2017
1ThrombospondinsIBA
01/2016
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2015
1Potassium Channels (Potassium Channel)IBA
10/2014
1ColforsinIBA
09/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
04/2013
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
03/2013
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2013
1Tyrosine (L-Tyrosine)FDA Link
03/2013
1ErbB Receptors (EGF Receptor)IBA
03/2013
1Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA
03/2013
1activin BIBA
12/2012
1activin AIBA
08/2012
1Caspase 3 (Caspase-3)IBA
02/2009
1AntralIBA
10/2006
1Hormones (Hormone)IBA
11/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
08/2016 - 02/2011
1Therapeutics
01/2019